Form 4 Filing for 10x Genomics, Inc.

This filing reports a sale of Class A Common Stock by Shehnaaz Suliman, a director at 10x Genomics, Inc. The transactions occurred on August 24, 2026, pursuant to a Rule 10b5-1 trading plan. A total of 561 shares were sold at a weighted average price of $62.73, resulting in 31,161 shares remaining. An additional 1,646 shares were sold at a weighted average price of $63.97, leaving 29,515 shares. The sales were executed at prices ranging from $62.26 to $64.29. The filing was signed by Randy Wu as Attorney-in-Fact for Shehnaaz Suliman.